Clinical Applications of System Regulation Medicine

Area of Science:

• Systems Biology
• Translational Medicine
• Computational Biology

Background:

• Chronic non-communicable diseases (NCDs) have increasing incidence and poor outcomes in Western populations.
• Current guideline-based treatments are often based on low-quality evidence, with significant numbers of patients experiencing no benefit from common drugs.
• Reductionist, linear medicine fails to address preclinical disease stages and the complexity of biological networks.

Purpose of the Study:

• To propose System Medicine as a paradigm shift for treating NCDs.
• To highlight the potential of targeting biological network dysregulations in the preclinical phase of disease.
• To advocate for a network-centric approach to reduce polypharmacy and improve treatment efficacy.

Main Methods:

• Conceptual framework development based on System Medicine principles.
• Analysis of current limitations in evidence-based medicine and drug efficacy.
• Exploration of biological network dynamics in disease pathogenesis and comorbidity development.

Main Results:

• System Medicine conceptualizes diseases as dynamic dysregulations within biological networks.
• Intervening in preclinical, dysregulated networks offers opportunities for disease prevention and reversal.
• Targeting shared biological networks, rather than individual symptoms, can decrease drug utilization and improve outcomes.

Conclusions:

• System Medicine provides a framework to address the limitations of current NCD treatment strategies.
• Early intervention in preclinical disease by targeting network dysregulations is a promising approach.
• A shift towards network-based treatments can enhance therapeutic effectiveness and reduce reliance on ineffective medications.